BSE filing, NSE: CUBEXTUB. Summary written from the filing by ALFA Finder's alert engine.
Cubex Tubings Ltd: key numbers
- Share price
- ₹184.00
- Market cap
- ₹263.5 Cr
- Revenue (annual)
- ₹288.0 Cr
- Net profit (annual)
- ₹7.45 Cr
- P/E (TTM)
- 25.4×Sector 16.7×
- Promoter holding
- 44.42%+0.00% QoQ
- FII holding
- 0.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cubex Tubings Ltd
All →Cubex Tubings Convertible Warrants
Cubex Tubings filed a corrigendum to its EGM notice for a preferential issue, adding objects-of-issue, post-issue shareholding, lock-in and compliance disclosures. The issue involves warrants convertible into equity, with the company raising ₹75 crore.
- Value
- ₹75.00 Cr
Cubex Tubings Results Update
Cubex Tubings Ltd released a Q2FY27 press release with unaudited standalone results, showing revenue of ₹82.99 Cr and PAT of ₹4.57 Cr. The release also notes a board-approved ₹75 Cr preferential warrant issue.
Cubex Tubings Q2 FY27 Results: Net Profit ₹4.6 Cr, Up 170.6% YoY
Cubex Tubings Ltd reported revenue from operations of ₹83 Cr (+12.6% YoY) and net profit of ₹4.6 Cr (+170.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.6 Cr · +170.6% YoY
Cubex Tubings Convertible Warrants
Cubex Tubings Limited has convened an EGM on November 6, 2026, to seek shareholder approval for issuing 50 lakh convertible warrants at Rs. 150 per warrant.
- Value
- ₹75.00 Cr
Cubex Tubings Fund Raise of ₹75 Cr
Cubex Tubings' board approved raising ₹75 Crore via the issuance of 50 lakh convertible warrants. This capital will fund a new vacuum melting furnace manufacturing facility.
- Value
- ₹75.00 Cr
Cubex Tubings Other Announcement
Cubex Tubings has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 regarding share dematerialization.
Other other announcement announcements
All →Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.
Schaeffler India Other Announcement
Schaeffler India disclosed that CRISIL ESG Ratings assigned it an ESG Score of 67 on an unsolicited basis. The company did not engage or subscribe to the rating provider.